CA2100777A1 - Pharmaceutical composition containing granisetron and dexamethasone - Google Patents

Pharmaceutical composition containing granisetron and dexamethasone

Info

Publication number
CA2100777A1
CA2100777A1 CA002100777A CA2100777A CA2100777A1 CA 2100777 A1 CA2100777 A1 CA 2100777A1 CA 002100777 A CA002100777 A CA 002100777A CA 2100777 A CA2100777 A CA 2100777A CA 2100777 A1 CA2100777 A1 CA 2100777A1
Authority
CA
Canada
Prior art keywords
dexamethasone
pharmaceutical composition
composition containing
granisetron
containing granisetron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002100777A
Other languages
French (fr)
Other versions
CA2100777C (en
Inventor
Gareth John Sanger
Christopher Stuart Dott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
Gareth John Sanger
Christopher Stuart Dott
Smithkline Beecham P.L.C.
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB919101221A priority Critical patent/GB9101221D0/en
Priority to GB9101221.1 priority
Application filed by Gareth John Sanger, Christopher Stuart Dott, Smithkline Beecham P.L.C., F. Hoffmann-La Roche Ag filed Critical Gareth John Sanger
Priority to PCT/GB1992/000091 priority patent/WO1992012716A1/en
Publication of CA2100777A1 publication Critical patent/CA2100777A1/en
Application granted granted Critical
Publication of CA2100777C publication Critical patent/CA2100777C/en
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof

Abstract

A pharmaceutical product comprising granisetron and dexamethasone as a combined preparation far simultaneous, sepa-rate or sequential use in the treatment and/or prevention of nausea and vomiting.
CA 2100777 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone Expired - Lifetime CA2100777C (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB919101221A GB9101221D0 (en) 1991-01-19 1991-01-19 Pharmaceuticals
GB9101221.1 1991-01-19
PCT/GB1992/000091 WO1992012716A1 (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone

Publications (2)

Publication Number Publication Date
CA2100777A1 true CA2100777A1 (en) 1992-07-20
CA2100777C CA2100777C (en) 2003-08-19

Family

ID=10688722

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2100777 Expired - Lifetime CA2100777C (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone

Country Status (12)

Country Link
EP (1) EP0567498A1 (en)
JP (1) JP3521143B2 (en)
KR (1) KR937002991A (en)
AU (1) AU658169B2 (en)
CA (1) CA2100777C (en)
GB (1) GB9101221D0 (en)
IE (1) IE920148A1 (en)
MX (1) MX9200214A (en)
NZ (1) NZ241337A (en)
PT (1) PT100033B (en)
WO (1) WO1992012716A1 (en)
ZA (1) ZA9200343B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
US20080241231A1 (en) * 2007-02-21 2008-10-02 Victory Pharma, Incorporated Transdermal delivery of dexamethasone and promethazine
JP5537104B2 (en) * 2009-09-16 2014-07-02 テルモ株式会社 Antiemetic
KR101368587B1 (en) * 2010-12-27 2014-03-05 주식회사 삼양바이오팜 Composition for prevention of nausea or vomiting
CN103222977A (en) * 2013-05-22 2013-07-31 南京工业大学 Granisetron and dexamethasone compound percutaneous controlled release patch and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650772T2 (en) * 1985-04-27 2003-04-03 Hoffmann La Roche Derivatives of indazoles-3-carboxamides and -3-carboxylic acid
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
GB9101221D0 (en) 1991-02-27
WO1992012716A1 (en) 1992-08-06
EP0567498A1 (en) 1993-11-03
MX9200214A (en) 1992-08-01
AU1164192A (en) 1992-08-27
KR937002991A (en) 1993-11-29
JPH06507152A (en) 1994-08-11
PT100033B (en) 1999-09-30
IE920148A1 (en) 1992-07-29
JP3521143B2 (en) 2004-04-19
AU658169B2 (en) 1995-04-06
NZ241337A (en) 1994-07-26
CA2100777C (en) 2003-08-19
PT100033A (en) 1993-02-26
ZA9200343B (en) 1992-12-30

Similar Documents

Publication Publication Date Title
EP0475160B8 (en) Preparation for drug application in minute droplet form
AU658163B2 (en) New nitrogenous bicyclic derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
AU687027B2 (en) 7-halo- and 7beta,8beta -methano-taxols, antineoplastic use and pharmaceutical compositions containing them
AU650754B2 (en) Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and pharmaceutical compositions containing them
AU685415B2 (en) Taxoids, preparation thereof and pharmaceutical compositions containing same
IL100740D0 (en) Biphenyl derivatives,their preparation and pharmaceutical compositions containing them
CA2154424A1 (en) 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect
IL92208D0 (en) 3-piperidinyl-1,2-benzisoxazoles,their preparation and pharmaceutical compositions containing them
AU3132493A (en) Hemoglobins as drug delivery agents
GR3030359T3 (en) Stable oral ci-981 formulation and process of preparing same.
NZ238011A (en) Composition containing two anti-parkinson drugs and osmotic dosage forms
IL101312D0 (en) Aminoguanidines,their preparation and pharmaceutical compositions containing them
NZ262170A (en) Trisubstituted phenyl derivatives, preparation and pharmaceutical compositions thereof
IL104311D0 (en) Pyrazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL99225D0 (en) 3-amidopyrazole derivatives,their preparation and pharmaceutical compositions containing them
IL91360D0 (en) Cyclodextrin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL101034A (en) 1-Biphenylimidazole derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
NZ314110A (en) The use of pyrazolopyrimidinone derivatives in preparing pharmaceutical compositions
AU2095092A (en) New arylethylamine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
IL102383A (en) Methylene-oxindole derivatives, their preparation and pharmacetutical compositions containing them
IE66110B1 (en) Optically active 5H-pyrrolo[3, 4-b]pyrazine derivative its preparation and pharmaceutical compositions containing it
IL105255D0 (en) Perhydroisoindole derivatives,their preparation and pharmaceutical compositions containing them
IL92377D0 (en) Quinuclidines,their preparation and pharmaceutical compositions comprising them
LT96039A (en) Oral pharmaceutical compositions, processes for preparation and use thereof
IL103198D0 (en) Benzanilide derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry